All About Cardiovascular System and Disorders

Omecamtiv mecarbil is a cardiac myosin activator being evaluated in the treatment of heart failure.

Ambulatory BP monitoring and home monitoring are two methods which have been developed to assess the ‘true’ blood pressure in an ideal setting.

ANTIPAF-Trial concluded that one year treatment with ARB in AF and no structural heart disease did not reduce the burden of paroxysmal AF.

Stent was superior to balloon angioplasty and surgery was superior to stent in coarctation of aorta, but with longer hospital stay.

High prevalence and high spontaneous closure rates of muscular VSDs have been noted by echocardiographic screening in neonates.

PCI in CAD associated with severe aortic stenosis could be performed no significant increased risk of short term mortality.

Polymer free amphilimus stent has lower in stent late lumen loss and better 1 year clinical safety and efficacy in treatment of de novo coronary lesions.

Newer antithrombotics in atrial fibrillation: DTI -dabigatran, direct factor Xa inhibitors - rivaroxaban, apixaban, edoxaban; vitamin K analogue tecarfarin.

Study found that degeneration of bioprosthetic valves is faster in patients with type 2 diabetes mellitus.

Simultaneous kissing stents are used in coronary bifurcation lesions only when the need for a future side branch access is deemed unlikely.